Syros Pharmaceuticals Inc Stock Ownership - Who owns Syros Pharmaceuticals?

Insider buying vs selling

Have Syros Pharmaceuticals Inc insiders been buying or selling?
Timothy TysonDirector2022-09-3014,000$6.37
Timothy TysonDirector2022-09-292,932$5.72
Eric R. OlsonChief Scientific Officer2022-04-0127,266$1.12
David RothChief Medical Officer2022-04-0127,281$1.12
Nancy A. SimonianPresident & CEO2022-04-0158,883$1.12
Kristin StephensChief Development Officer2022-04-0114,115$1.12

1 of 1

SYRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SYRS insiders and whales buy or sell their stock.

SYRS Shareholders

What type of owners hold Syros Pharmaceuticals Inc stock?
Robert Nelsen23.98%4,850,470$21.83MInsider
Arch Venture Fund Vii LP20.97%4,242,051$19.09MInsider
Srinivas Akkaraju18.29%3,700,294$16.65MInsider
Flagship Ventures Fund Iv LP11.88%2,403,190$10.81MInsider
James E. Flynn10.36%2,095,220$9.43MInsider
Artal Group Sa7.24%1,463,829$6.59MInstitution
Bain Capital Life Sciences Investors LLC5.35%1,082,404$4.87MInstitution
Flagship Pioneering Inc4.91%993,848$4.47MInstitution
Wuxi Pharmtech Healthcare Fund I LP4.61%931,857$4.19MInsider
Aisling Capital Iii LP4.49%908,565$4.09MInsider

1 of 3

SYRS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SYRS29.18%70.82%Net Selling
ETON25.08%22.13%Net Buying
FSTX31.50%20.68%Net Buying

Syros Pharmaceuticals Stock Ownership FAQ

Who owns Syros Pharmaceuticals?

Syros Pharmaceuticals (NASDAQ: SYRS) is owned by 46.03% institutional shareholders, 111.72% Syros Pharmaceuticals insiders, and 0.00% retail investors. Robert Nelsen is the largest individual Syros Pharmaceuticals shareholder, owning 4.85M shares representing 23.98% of the company. Robert Nelsen's Syros Pharmaceuticals shares are currently valued at $21.83M.

If you're new to stock investing, here's how to buy Syros Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.